Details for New Drug Application (NDA): 071002
✉ Email this page to a colleague
NDA 071002 describes MIDOL, which is a drug marketed by Bayer and Bionpharma and is included in five NDAs. Additional details are available on the MIDOL profile page.
The generic ingredient in MIDOL is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and forty-two suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.
The generic ingredient in MIDOL is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and forty-two suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.
Medical Subject Heading (MeSH) Categories for 071002
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Sep 2, 1987 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
